KORBEXLY

Serial Number 98910518
686

Registration Progress

Application Filed
Dec 18, 2024
Under Examination
Approved for Publication
Jul 8, 2025
Published for Opposition
Jul 8, 2025
Registered

Attorney Assistance

Notice of Publication
Due: Aug 07, 2025 3 days

Trademark Image

KORBEXLY

Basic Information

Serial Number
98910518
Filing Date
December 18, 2024
Published for Opposition
July 8, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jul 8, 2025
Application
Pending
Classes
005

Rights Holder

Takeda Pharmaceuticals International AG

99
Address
Thurgauerstrasse 130
Glattpark-Opfikon 8152
CH

Ownership History

Takeda Pharmaceuticals International AG

Original Applicant
99
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Owner at Publication
99
Glattpark-Opfikon CH

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

Next Deadline
3 days remaining
Notice of Publication
Due Date
August 07, 2025
Extension Available
Until September 07, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

18 events
Date Code Type Description Documents
Jul 8, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 8, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 2, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 4, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 29, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 29, 2025 ALIE A ASSIGNED TO LIE Loading...
May 29, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 16, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
May 14, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 14, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 14, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
May 14, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 14, 2025 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
May 14, 2025 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
May 14, 2025 CNSL R SUSPENSION LETTER WRITTEN Loading...
May 13, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 18, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 18, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and management of the central nervous system conditions; pharmaceutical preparations for the treatment and management of sleep disorders.

Classification

International Classes
005